Compounds > sofosbuvir
Page last updated: 2024-08-25

sofosbuvir and guanosine monophosphate

sofosbuvir has been researched along with guanosine monophosphate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Lawitz, EJ; Membreno, FE1
Ahmadyar, S; Babusis, D; Barauskas, O; Feng, JY; McCutcheon, K; Park, Y; Perron, M; Perry, JK; Ray, AS; Sakowicz, R; Schultz, BE; Stepan, G; Xu, Y; Yu, H1
Amblard, F; Amiralaei, S; Cho, JH; Coats, SJ; Domaoal, RA; Ehteshami, M; Khalil, A; Lee, SS; Lin, B; Lu, X; Ozturk, T; Schinazi, RF; Shelton, JR; Stanton, RA; Suesserman, JE; Tao, S; Whitaker, T; Zhang, H; Zhou, L1
Behera, I; Beigelman, L; Chaudhuri, S; Deval, J; Dyatkina, N; Jekle, A; Jin, Z; Kinkade, A; Rajwanshi, VK; Smith, DB; Symons, JA; Tucker, K; Wang, G1
Elfiky, AA1

Reviews

1 review(s) available for sofosbuvir and guanosine monophosphate

ArticleYear
The HCV NS5B nucleoside and non-nucleoside inhibitors.
    Clinics in liver disease, 2011, Volume: 15, Issue:3

    Topics: Antiviral Agents; Clinical Trials as Topic; Deoxycytidine; Guanosine Monophosphate; Hepatitis C; Humans; Sofosbuvir; Uridine Monophosphate; Viral Nonstructural Proteins

2011

Other Studies

4 other study(ies) available for sofosbuvir and guanosine monophosphate

ArticleYear
Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:2

    Topics: Antiviral Agents; Cell Line; Deoxycytidine; DNA Polymerase gamma; DNA-Directed DNA Polymerase; DNA-Directed RNA Polymerases; Guanosine Monophosphate; Hepacivirus; Hepatitis C, Chronic; Humans; Mitochondria; Nucleosides; Oxygen Consumption; Protein Biosynthesis; RNA; RNA, Mitochondrial; Sofosbuvir; Transcription, Genetic; Virus Replication

2016
Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8

    Topics: Adenosine; Antiviral Agents; Cell Line; DNA-Directed RNA Polymerases; Guanosine Monophosphate; Hepacivirus; Hepatitis C; Humans; Prodrugs; Ribonucleosides; RNA; RNA, Mitochondrial; RNA, Viral; Sofosbuvir; Transcription, Genetic; Viral Nonstructural Proteins; Virus Replication

2016
Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs.
    Antiviral research, 2017, Volume: 143

    Topics: Adenosine; Amides; Antiviral Agents; Cell Line; Cytidine; DNA-Directed RNA Polymerases; Guanosine Monophosphate; Humans; Inhibitory Concentration 50; Mitochondria; Mitochondrial Proteins; Nucleosides; Prodrugs; Protein Biosynthesis; Pyrazines; Ribonucleosides; RNA; RNA, Mitochondrial; Sofosbuvir; Structure-Activity Relationship; Transcription Initiation Site; Transcription, Genetic

2017
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
    Life sciences, 2020, May-01, Volume: 248

    Topics: Adenosine Monophosphate; Alanine; Alphacoronavirus; Amino Acid Sequence; Antiviral Agents; Betacoronavirus; Catalytic Domain; Computational Biology; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Guanosine Monophosphate; Guanosine Triphosphate; Humans; Molecular Docking Simulation; Pneumonia, Viral; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Ribavirin; RNA-Dependent RNA Polymerase; SARS-CoV-2; Sequence Alignment; Sequence Homology, Amino Acid; Sofosbuvir; Thermodynamics; Uridine Triphosphate; Viral Proteins

2020